Company news
Iradimed Corporation (NASDAQ:IRMD) news
Iradimed Corporation news releases on 6ix. Latest, Sep 23, 2026: IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
Press releases & updates
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
September 23, 2026
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
July 31, 2026
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
July 24, 2026
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 20, 2026
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
April 30, 2026
IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026
April 27, 2026
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
April 10, 2026
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
March 15, 2026
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
February 10, 2026
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
February 4, 2026
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
December 7, 2025
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
November 9, 2025
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
November 2, 2025
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025
October 26, 2025
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
September 1, 2025
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
August 25, 2025
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
July 31, 2025
IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025
July 24, 2025
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
May 28, 2025
IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
May 4, 2025
CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
April 28, 2025
IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
April 27, 2025
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
March 9, 2025
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
February 12, 2025
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
January 29, 2025
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
January 9, 2025
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
December 9, 2024
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
November 3, 2024
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
October 30, 2024
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
October 23, 2024
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
October 2, 2024
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
September 9, 2024
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
July 31, 2024
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
July 24, 2024
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
June 6, 2024
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
May 1, 2024
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
April 24, 2024
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
March 12, 2024
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
February 7, 2024
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
January 31, 2024
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
January 8, 2024
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 1, 2024
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
December 11, 2023
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
November 29, 2023
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
November 2, 2023
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
October 25, 2023
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
September 5, 2023
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
August 2, 2023
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
July 26, 2023